Chinese Traditional and Herbal Drugs
|
2025, 56(13): 4914-4925
Research progress on co-delivery nano-formulations of traditional Chinese medicine monomers and chemotherapeutic drugs for liver cancer treatment
Full
WEI Shengwei1, SU Mingzhe1, XIAO Xiuqiong1, ZHOU Huanhuan2, CHEN Haiyan1, PENG Shiya1, ZHANG Yuyan1, ZHU Yu1, YE Yong1,3,4
Affiliations
1 School of Pharmacy, Guangxi Medical University, Nanning 530021, China; 2 The First Clinical Medical College of Guangxi Medical University, Nanning 530021, China; 3 Guangxi Key Laboratory of Bioactive Molecules Research and Evaluation, Nanning 530021, China; 4 University Engineering Research Center of Prevention and Treatment of Major Diseases in the Elderly and Biomedical Translation, Nanning 530021, China
About Author:
广西自然科学基金资助项目 (2022GXNSFDA035063); 广西自然科学基金资助项目 (2023GXNSFAA026366); 国家自然科学基金资助项目 (82360818); 国家自然科学基金资助项目 (81960756)
doi: 10.7501/j.issn.0253-2670.2025.13.033
Outline
Primary liver cancer is one of the malignant tumors with high incidence and mortality rates worldwide. In its treatment, single-drug therapies are often limited by toxic side effects and drug resistance. Combination therapy can exert multi-mechanism synergistic effects to enhance efficacy, reduce toxic side effects, and delay the development of drug resistance. Traditional Chinese medicine (TCM) monomers, which exhibit potent anti-liver cancer activity, lower toxicity, and the ability to counteract chemotherapy-induced damage to normal tissues, are frequently used in combination with chemotherapeutic drugs for liver cancer treatment. Nano-formulations enable synchronized absorption and distribution of combined drugs, thereby enhancing their synergistic effects, and are widely used for the loading and delivery of co-administered drugs. This article reviews the advantages of combining chemotherapeutic drugs with TCM monomers, the benefits of nano co-delivery, and recent research progress in co-delivery nano-formulations of TCM monomers and chemotherapeutic drugs for liver cancer treatment, aiming to provide insights for advancing research on combination therapy against liver cancer.
liver cancer
/
traditional Chinese medicine monomer
/
combined administration
/
nano-formulation
/
co-delivery
/
advantage
韦盛伟, 苏明哲, 肖秀琼, 周欢欢, 陈海燕, 彭诗雅, 张裕彦, 朱煜, 叶勇.
中药单体与化疗药物共载纳米制剂治疗肝癌研究进展.
中草药,
2025
, 56
(13)
: 4914
-4925
.
DOI: 10.7501/j.issn.0253-2670.2025.13.033
WEI Shengwei, SU Mingzhe, XIAO Xiuqiong, ZHOU Huanhuan, CHEN Haiyan, PENG Shiya, ZHANG Yuyan, ZHU Yu, YE Yong.
Research progress on co-delivery nano-formulations of traditional Chinese medicine monomers and chemotherapeutic drugs for liver cancer treatment[J].
Chinese Traditional and Herbal Drugs,
2025
, 56
(13)
: 4914
-4925
.
DOI: 10.7501/j.issn.0253-2670.2025.13.033
Year 2025 volume 56 Issue 13
43
0
Cite this Article
BibTeX
Article Info
doi: 10.7501/j.issn.0253-2670.2025.13.033
- Receive Date:2025-03-03
- Online Date:2026-11-12